FDA approves osteoarthritis drug from Nuvo Research
Canadian biotech firm Nuvo Research gained FDA approval for Pennsaid, a topical pain treatment for osteoarthritis of the knee. Nuvo and partner Covidien plan to introduce the product in the U.S. in the first half of 2010.
Reuters | 11/05
This story published in FDLI SmartBrief on 11/06/2009
More from SmartBrief:
FDA to take more time reviewing Pennsaid
Wednesday, August 5, 2009
FDA flags Q-Med on efficacy of knee pain gel
Tuesday, August 18, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|